Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2011 - 2026)

Pharma-Bio Serv's Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.73 for Q2 2026.

• Quarterly Asset Utilization Ratio rose 13.12% year-over-year to 0.73 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.73 (up 13.12% YoY) and the FY2025 annual result came in at 0.6, up 14.41% from the prior year.
• Asset Utilization Ratio was 0.73 for Q2 2026 at Pharma-Bio Serv, up from 0.65 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.01 in Q3 2022 and bottomed at 0.58 in Q4 2024.
• A 5-year average of 0.77 and a median of 0.75 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 45.34% — and 2024, when it plunged 30.95%.
• Pharma-Bio Serv's Asset Utilization Ratio stood at 0.95 in 2022, then decreased by 10.78% to 0.84 in 2023, then plunged by 30.95% to 0.58 in 2024, then climbed by 13.32% to 0.66 in 2025, then gained by 10.07% to 0.73 in 2026.
• Business Quant data shows PBSV's Asset Utilization Ratio at 0.73 in Q2 2026, 0.65 in Q1 2026, and 0.66 in Q4 2025.